Diagnostic Testing For Sars-Cov-2: State Of The Art And Perspectives Of Molecular Salivary Testing

OBJECTIVESClosing commercial, recreational and educational activities is one of the most frequently adopted measures worldwide, to respond to the COVID-19 pandemic. Beyond their positive effect, however, such measures present negative economic, educational, and psychological aspects on the population. To reduce these disadvantages, together with vaccines and therapies, it is crucial to develop efficient tools for early diagnosis and to rapidly interrupt the infective chain. especially in particularly susceptible communities.This dossier aims to provide an overview of the currently available diagnostic tests for SARS-CoV-2, with an insight in salivary molecular tests.MATERIALS AND METHODSThe present dossier reviews the currently available diagnostic tests for SARS-CoV-2 with a focus on salivary molecular tests, used within an experimental protocol by the UNIMI SAL research group of University degli Studi of Milan. The dossier includes an overview of COVID-19. a narrative review of the literature and a paradigmatic case report that highlights the characteristics and potential use of the different available tests.RESULTSThe diagnostic SARS-CoV-2 tests can be classified according to the target they aim to detect, that is viral RNA, antigens or antibodies. The currently official diagnostic tool is the naso-pharyngeal molecular swab, due to its high sensibility (>98%) and specificity (>99%). A farther tool is the antigenic swab, that, despite the advantage of a rapid result, is less accurate and whose positive result needs therefore to be confirmed by a naso-pharyngeal molecular swab. Serological tests find their optimal application in epidemiological screenings concerning the anti- body status of individuals but are not strictly diagnostic. reason why a positive outcome requires to be followed by a naso-pharyngeal molecular swab.Serological tests find their optimal application in epidemiological screenings concerning the anti- body status of individuals but are not strictly diagnostic. reason why a positive outcome requires to be followed by a naso-pharyngeal molecular swab.Salivary molecular tests is under validation. It is a non-invasive tool that can be self-performed and shows a high concordance with naso-pharyngeal molecular swabs. Salivary molecular tests will be described in the context of an experimental protocol by the UNIMI SAL research group of University degli Studi of Milan. Saliva. collected by means of a dental cotton roll, was obtained in different settings. both from adults and children, and its analysis provided promising results thanks to its high concordance with naso-pharyngeal molecular swabs and its ability to early detect positive asymptomatic and pre-symptomatic.CONCLUSIONSThe COVID-19 pandemic has prompted an increased request for new diagnostic and therapeutic possibilities in short times. To implement research towards new and innovative tools useful to overcome the difficulties connected to closures and stay-at-home measures, is crucial. In this context, salivary molecular tests seem to provide the adequate characteristics for active surveillance and early detection of positive cases.CLINICAL SIGNIFICANCEKnowledge of different diagnostic tests and their applicability is fundamental for all health workers. The comprehension of the different available devices and methods on the market for rapid and not rapid detection of SARS-CoV-2, is useful in the management of their daily clinical activity.